CDC panel recommends resuming use of J&J’s Covid vaccine
Published
US scientific advisers say benefits of the single-shot jab outweigh the risk of rare blood clots
Full ArticlePublished
US scientific advisers say benefits of the single-shot jab outweigh the risk of rare blood clots
Full ArticleA US medical panel has recommended resuming the use of the Johnson & Johnson COVID-19 vaccine.
A US health panel says it is time to resume use of Johnson & Johnson’s Covid-19 vaccine, despite a very rare risk of blood clots.